Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOTIC-VTE seamless anticoagulant therapy in gynecological cancer
jRCTs031180124Completed
- Sponsor
- Gynecologic Oncology Trial and Investigation Consortium
- Start
- Nov 2017
- Countries
- 1
01
Overview
Open-label trial in gynecological cancer, endometrial cancer (EC), Cervical Cancer (CC) and 6 more (2 cohorts), sponsored by Gynecologic Oncology Trial and Investigation Consortium. Primary endpoints: Registry baseline VTE frequency, Registry 1-year symptomatic VTE incidence and 2 more. Started Nov 2017; status: completed.
02
Conditions
gynecological cancerendometrial cancer (EC)Cervical Cancer (CC)Ovarian Epithelial Adenocarcinomafallopian tube cancer (PFTC)
Beyond the preview
Go deeper on jRCTs031180124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180124.